XLO

About Xilio Therapeutics, Inc. Common Stock (XLO) Stock

Xilio Therapeutics, Inc. Common Stock (XLO) closed the 2026-09-18 session at $9.13, up 1.00% versus the previous close (+0.09). The stock opened at $8.99 and traded between $8.94 and $9.67 during that session. Session trading volume was 23K shares. The volume-weighted average price (VWAP) is $9.13.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Xilio Therapeutics, Inc. Common Stock has a market capitalization of $60.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. XLO is listed on the XNAS exchange. The company employs approximately 76 people. Xilio Therapeutics, Inc. Common Stock is headquartered in WALTHAM, MA. The recorded listing date is 2021-10-22.

On this page you can find market XLO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.